Does the media refer more to GMED or TMDX?

In the previous week, TransMedics Group had 6 more articles in the media than Globus Medical. MarketBeat recorded 16 mentions for TransMedics Group and 10 mentions for Globus Medical. TransMedics Group's average media sentiment score of 1.16 beat Globus Medical's score of 0.75 indicating that TransMedics Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Globus Medical 4 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TransMedics Group 12 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, GKOS or TMDX?

TransMedics Group has lower revenue, but higher earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Glaukos $612.84M 17.15 -$187.69M -$3.25 N/A TransMedics Group $605.49M 5.14 $190.29M $3.89 23.13

Does the media refer more to GKOS or TMDX?

In the previous week, TransMedics Group had 10 more articles in the media than Glaukos. MarketBeat recorded 16 mentions for TransMedics Group and 6 mentions for Glaukos. Glaukos' average media sentiment score of 1.68 beat TransMedics Group's score of 1.16 indicating that Glaukos is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Glaukos 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive TransMedics Group 12 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, PODD or TMDX?

Insulet has higher revenue and earnings than TransMedics Group. TransMedics Group is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Insulet $2.71B 3.78 $247.10M $5.35 27.57 TransMedics Group $605.49M 5.14 $190.29M $3.89 23.13

Does the media favor PODD or TMDX?

In the previous week, TransMedics Group had 1 more articles in the media than Insulet. MarketBeat recorded 16 mentions for TransMedics Group and 15 mentions for Insulet. TransMedics Group's average media sentiment score of 1.16 beat Insulet's score of 0.87 indicating that TransMedics Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Insulet 8 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TransMedics Group 12 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer TMDX or TFX?

In the previous week, TransMedics Group had 4 more articles in the media than Teleflex. MarketBeat recorded 16 mentions for TransMedics Group and 12 mentions for Teleflex. TransMedics Group's average media sentiment score of 1.16 beat Teleflex's score of 0.96 indicating that TransMedics Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransMedics Group 12 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teleflex 6 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MMED or TMDX?

In the previous week, MiniMed Group had 18 more articles in the media than TransMedics Group. MarketBeat recorded 34 mentions for MiniMed Group and 16 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 1.16 beat MiniMed Group's score of 0.72 indicating that TransMedics Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 11 Very Positive mention(s) 5 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TransMedics Group 12 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

TransMedics Group (TMDX) Competitors

$89.98 +3.00 (+3.45%)

As of 09/4/2026 04:00 PM Eastern

Compare

TMDX vs. GMED, GKOS, PODD, TFX, and MMED

Should you buy TransMedics Group stock or one of its competitors? TransMedics Group's main competitors and comparable companies include Globus Medical (GMED), Glaukos (GKOS), Insulet (PODD), Teleflex (TFX), and MiniMed Group (MMED). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does TransMedics Group compare to Globus Medical?

Globus Medical (NYSE:GMED) and TransMedics Group (NASDAQ:TMDX) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.

Globus Medical has higher revenue and earnings than TransMedics Group. Globus Medical is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Globus Medical	$2.94B	3.58	$537.87M	$3.91	20.02
TransMedics Group	$605.49M	5.14	$190.29M	$3.89	23.13

Globus Medical has a beta of 0.95, indicating that its share price is 5% less volatile than the broader market. Comparatively, TransMedics Group has a beta of 1.9, indicating that its share price is 90% more volatile than the broader market.

95.2% of Globus Medical shares are held by institutional investors. Comparatively, 99.7% of TransMedics Group shares are held by institutional investors. 18.4% of Globus Medical shares are held by insiders. Comparatively, 6.9% of TransMedics Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, TransMedics Group had 6 more articles in the media than Globus Medical. MarketBeat recorded 16 mentions for TransMedics Group and 10 mentions for Globus Medical. TransMedics Group's average media sentiment score of 1.16 beat Globus Medical's score of 0.75 indicating that TransMedics Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Globus Medical	4 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
TransMedics Group	12 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

TransMedics Group has a net margin of 22.69% compared to Globus Medical's net margin of 17.02%. TransMedics Group's return on equity of 15.88% beat Globus Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Globus Medical	17.02%	14.57%	12.62%
TransMedics Group	22.69%	15.88%	5.95%

Globus Medical currently has a consensus target price of $101.77, indicating a potential upside of 30.02%. TransMedics Group has a consensus target price of $124.18, indicating a potential upside of 38.01%. Given TransMedics Group's higher probable upside, analysts clearly believe TransMedics Group is more favorable than Globus Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88
TransMedics Group	1 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

Summary

TransMedics Group beats Globus Medical on 9 of the 17 factors compared between the two stocks.

How does TransMedics Group compare to Glaukos?

Glaukos (NYSE:GKOS) and TransMedics Group (NASDAQ:TMDX) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, institutional ownership, valuation, risk, analyst recommendations and earnings.

Glaukos has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market. Comparatively, TransMedics Group has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market.

99.0% of Glaukos shares are held by institutional investors. Comparatively, 99.7% of TransMedics Group shares are held by institutional investors. 5.9% of Glaukos shares are held by company insiders. Comparatively, 6.9% of TransMedics Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

TransMedics Group has lower revenue, but higher earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Glaukos	$612.84M	17.15	-$187.69M	-$3.25	N/A
TransMedics Group	$605.49M	5.14	$190.29M	$3.89	23.13

Glaukos presently has a consensus price target of $178.08, indicating a potential downside of 0.07%. TransMedics Group has a consensus price target of $124.18, indicating a potential upside of 38.01%. Given TransMedics Group's higher possible upside, analysts plainly believe TransMedics Group is more favorable than Glaukos.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glaukos	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.79
TransMedics Group	1 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

In the previous week, TransMedics Group had 10 more articles in the media than Glaukos. MarketBeat recorded 16 mentions for TransMedics Group and 6 mentions for Glaukos. Glaukos' average media sentiment score of 1.68 beat TransMedics Group's score of 1.16 indicating that Glaukos is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Glaukos	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
TransMedics Group	12 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

TransMedics Group has a net margin of 22.69% compared to Glaukos' net margin of -30.68%. TransMedics Group's return on equity of 15.88% beat Glaukos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Glaukos	-30.68%	-6.37%	-4.78%
TransMedics Group	22.69%	15.88%	5.95%

Summary

TransMedics Group beats Glaukos on 11 of the 16 factors compared between the two stocks.

How does TransMedics Group compare to Insulet?

Insulet (NASDAQ:PODD) and TransMedics Group (NASDAQ:TMDX) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

TransMedics Group has a net margin of 22.69% compared to Insulet's net margin of 12.29%. Insulet's return on equity of 29.29% beat TransMedics Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Insulet	12.29%	29.29%	13.31%
TransMedics Group	22.69%	15.88%	5.95%

Insulet has higher revenue and earnings than TransMedics Group. TransMedics Group is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insulet	$2.71B	3.78	$247.10M	$5.35	27.57
TransMedics Group	$605.49M	5.14	$190.29M	$3.89	23.13

99.7% of TransMedics Group shares are held by institutional investors. 0.4% of Insulet shares are held by company insiders. Comparatively, 6.9% of TransMedics Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Insulet presently has a consensus target price of $195.40, indicating a potential upside of 32.49%. TransMedics Group has a consensus target price of $124.18, indicating a potential upside of 38.01%. Given TransMedics Group's higher possible upside, analysts clearly believe TransMedics Group is more favorable than Insulet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insulet	2 Sell rating(s)	11 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.44
TransMedics Group	1 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

Insulet has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market. Comparatively, TransMedics Group has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market.

In the previous week, TransMedics Group had 1 more articles in the media than Insulet. MarketBeat recorded 16 mentions for TransMedics Group and 15 mentions for Insulet. TransMedics Group's average media sentiment score of 1.16 beat Insulet's score of 0.87 indicating that TransMedics Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Insulet	8 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
TransMedics Group	12 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Insulet and TransMedics Group tied by winning 8 of the 16 factors compared between the two stocks.

How does TransMedics Group compare to Teleflex?

TransMedics Group (NASDAQ:TMDX) and Teleflex (NYSE:TFX) are both mid-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

TransMedics Group has higher earnings, but lower revenue than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransMedics Group	$605.49M	5.14	$190.29M	$3.89	23.13
Teleflex	$2.25B	2.60	-$905.64M	-$23.29	N/A

In the previous week, TransMedics Group had 4 more articles in the media than Teleflex. MarketBeat recorded 16 mentions for TransMedics Group and 12 mentions for Teleflex. TransMedics Group's average media sentiment score of 1.16 beat Teleflex's score of 0.96 indicating that TransMedics Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransMedics Group	12 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teleflex	6 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

99.7% of TransMedics Group shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 6.9% of TransMedics Group shares are owned by insiders. Comparatively, 0.7% of Teleflex shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

TransMedics Group has a beta of 1.9, indicating that its share price is 90% more volatile than the broader market. Comparatively, Teleflex has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market.

TransMedics Group has a net margin of 22.69% compared to Teleflex's net margin of -39.67%. TransMedics Group's return on equity of 15.88% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransMedics Group	22.69%	15.88%	5.95%
Teleflex	-39.67%	11.93%	5.44%

TransMedics Group presently has a consensus target price of $124.18, suggesting a potential upside of 38.01%. Teleflex has a consensus target price of $152.90, suggesting a potential upside of 10.63%. Given TransMedics Group's higher possible upside, equities analysts clearly believe TransMedics Group is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransMedics Group	1 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38
Teleflex	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42

Summary

TransMedics Group beats Teleflex on 14 of the 17 factors compared between the two stocks.

How does TransMedics Group compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and TransMedics Group (NASDAQ:TMDX) are both mid-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation, media sentiment and earnings.

MiniMed Group presently has a consensus price target of $23.77, suggesting a potential upside of 2.10%. TransMedics Group has a consensus price target of $124.18, suggesting a potential upside of 38.01%. Given TransMedics Group's higher probable upside, analysts plainly believe TransMedics Group is more favorable than MiniMed Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75
TransMedics Group	1 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

TransMedics Group has a net margin of 22.69% compared to MiniMed Group's net margin of 0.00%. TransMedics Group's return on equity of 15.88% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
TransMedics Group	22.69%	15.88%	5.95%

TransMedics Group has lower revenue, but higher earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$3.10B	2.11	-$333M	-$0.68	N/A
TransMedics Group	$605.49M	5.14	$190.29M	$3.89	23.13

99.7% of TransMedics Group shares are held by institutional investors. 0.0% of MiniMed Group shares are held by insiders. Comparatively, 6.9% of TransMedics Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, MiniMed Group had 18 more articles in the media than TransMedics Group. MarketBeat recorded 34 mentions for MiniMed Group and 16 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 1.16 beat MiniMed Group's score of 0.72 indicating that TransMedics Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	11 Very Positive mention(s)	5 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
TransMedics Group	12 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

TransMedics Group beats MiniMed Group on 11 of the 15 factors compared between the two stocks.

Get TransMedics Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TMDX vs. The Competition

Export

Metric	TransMedics Group	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.11B	$5.76B	$7.25B	$12.91B
Dividend Yield	N/A	1.76%	2.53%	9.14%
P/E Ratio	23.13	25.94	274.10	25.45
Price / Sales	5.14	85.20	687.94	125.94
Price / Cash	22.91	32.98	77.08	52.44
Price / Book	6.00	6.06	12.85	6.17
Net Income	$190.29M	$150.92M	$3.49B	$350.08M
7 Day Performance	1.75%	-1.22%	1.04%	-0.14%
1 Month Performance	12.18%	2.18%	5.39%	0.94%
1 Year Performance	-13.49%	9.95%	24.18%	14.02%

TransMedics Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TMDX TransMedics Group	4.479 of 5 stars	$89.98 +3.4%	$124.18 +38.0%	-13.5%	$3.11B	$605.49M	23.13	210	News Coverage Positive News Gap Down
GMED Globus Medical	4.5473 of 5 stars	$81.06 -2.3%	$101.77 +25.5%	+29.3%	$10.88B	$2.94B	20.73	6,000	News Coverage
GKOS Glaukos	1.6127 of 5 stars	$178.44 -0.8%	$178.08 -0.2%	+90.1%	$10.53B	$612.84M	N/A	1,094	Positive News
PODD Insulet	4.1883 of 5 stars	$148.70 +2.5%	$195.40 +31.4%	-57.7%	$10.31B	$2.71B	27.79	5,400
TFX Teleflex	3.7312 of 5 stars	$141.23 +1.1%	$152.90 +8.3%	+5.8%	$5.98B	$1.99B	N/A	15,500

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TMDX) was last updated on 9/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

TransMedics Group (TMDX) Competitors

TMDX vs. GMED, GKOS, PODD, TFX, and MMED

How does TransMedics Group compare to Globus Medical?

Summary

How does TransMedics Group compare to Glaukos?

Summary

How does TransMedics Group compare to Insulet?

Summary

How does TransMedics Group compare to Teleflex?

Summary

How does TransMedics Group compare to MiniMed Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMDX vs. The Competition

TransMedics Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

TransMedics Group (TMDX) Competitors

TMDX vs. GMED, GKOS, PODD, TFX, and MMED

How does TransMedics Group compare to Globus Medical?

Which has higher valuation & earnings, GMED or TMDX?

Which has more volatility and risk, GMED or TMDX?

Do institutionals & insiders believe in GMED or TMDX?

Does the media refer more to GMED or TMDX?

Is GMED or TMDX more profitable?

Do analysts recommend GMED or TMDX?

Summary

How does TransMedics Group compare to Glaukos?

Which has more risk & volatility, GKOS or TMDX?

Do institutionals and insiders believe in GKOS or TMDX?

Which has preferable earnings and valuation, GKOS or TMDX?

Do analysts recommend GKOS or TMDX?

Does the media refer more to GKOS or TMDX?

Is GKOS or TMDX more profitable?

Summary

How does TransMedics Group compare to Insulet?

Is PODD or TMDX more profitable?

Which has preferable earnings and valuation, PODD or TMDX?

Do institutionals & insiders believe in PODD or TMDX?

Do analysts recommend PODD or TMDX?

Which has more risk and volatility, PODD or TMDX?

Does the media favor PODD or TMDX?

Summary

How does TransMedics Group compare to Teleflex?

Which has higher valuation and earnings, TMDX or TFX?

Does the media prefer TMDX or TFX?

Do institutionals and insiders hold more shares of TMDX or TFX?

Which has more volatility and risk, TMDX or TFX?

Is TMDX or TFX more profitable?

Do analysts recommend TMDX or TFX?

Summary

How does TransMedics Group compare to MiniMed Group?

Do analysts recommend MMED or TMDX?

Is MMED or TMDX more profitable?

Which has better valuation and earnings, MMED or TMDX?

Do insiders and institutionals have more ownership in MMED or TMDX?

Does the media favor MMED or TMDX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMDX vs. The Competition

TransMedics Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools